4.7 Article

Endogenous Oxalate Production in Primary Hyperoxaluria Type 1 Patients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Endocrinology & Metabolism

The effects of hydroxychloroquine on insulin sensitivity, insulin clearance and inflammation in insulin-resistant adults: A randomized trial

Frederico G. S. Toledo et al.

Summary: The study found that hydroxychloroquine improves skeletal muscle insulin sensitivity and systemic glucose clearance, but has no effect on hepatic insulin sensitivity or insulin clearance. Additionally, hydroxychloroquine decreases circulating IL-6 levels and increases adiponectin.

DIABETES OBESITY & METABOLISM (2021)

Article Medicine, General & Internal

Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1

Sander F. Garrelfs et al.

Summary: Primary hyperoxaluria type 1 is a rare genetic disease caused by hepatic overproduction of oxalate, leading to kidney stones, nephrocalcinosis, kidney failure, and systemic oxalosis. This trial tested the efficacy of lumasiran, an RNAi therapeutic agent, in reducing hepatic oxalate production. The results showed that lumasiran significantly reduced urinary oxalate excretion, alleviating the cause of kidney failure in PH1 patients.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Urology & Nephrology

Hydroxyproline Metabolism and Oxalate Synthesis in Primary Hyperoxaluria

Sonia Fargue et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)

Article Urology & Nephrology

Urine oxalate biological variation in patients with primary hyperoxaluria

Oliver Clifford-Mobley et al.

UROLITHIASIS (2016)

Article Urology & Nephrology

Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria

Katharina Hopp et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)

Article Urology & Nephrology

Vitamin B6 in Primary Hyperoxaluria I: First Prospective Trial after 40 Years of Practice

Heike Hoyer-Kuhn et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)

Article Biochemistry & Molecular Biology

Multiple mechanisms of action of pyridoxine in primary hyperoxaluria type 1

Sonia Fargue et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)

Review Medicine, General & Internal

Primary Hyperoxaluria

Pierre Cochat et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Transplantation

Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment

Pierre Cochat et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)

Article Endocrinology & Metabolism

Metabolism of primed, constant infusions of [1,2-13C2] glycine and [1-13C1] phenylalanine to urinary oxalate

John Knight et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2011)

Article Surgery

Transplantation Outcomes in Primary Hyperoxaluria

E. J. Bergstralh et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2010)

Article Medicine, General & Internal

A New Equation to Estimate Glomerular Filtration Rate

Andrew S. Levey et al.

ANNALS OF INTERNAL MEDICINE (2009)

Article Nutrition & Dietetics

Glutathione synthesis rates after amino acid administration directly after birth in preterm infants

Frans W. J. te Braake et al.

AMERICAN JOURNAL OF CLINICAL NUTRITION (2008)

Review Urology & Nephrology

The roles and mechanisms of intestinal oxalate transport in oxalate homeostasis

Marguerite Hatch et al.

SEMINARS IN NEPHROLOGY (2008)

Article Transplantation

Primary hyperoxaluria type 1 in The Netherlands: prevalence and outcome

CS van Woerden et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)

Article Urology & Nephrology

Contribution of dietary oxalate to urinary oxalate excretion

RP Holmes et al.

KIDNEY INTERNATIONAL (2001)